Perrigo Company PLC (NYSE:PRGO)
| 39.73 Delayed Data As of Jan 14 |  +0.11 / +0.28%Today’s Change | 35.34 Today|||52-Week Range 50.90 | +2.13% Year-to-Date |
Latest PRGO News | Press Releases
No recent news for Perrigo Company PLC.
Today’s Trading
| Previous close | 39.62 |
| Today’s open | 39.59 |
| Day’s range | 39.15 - 40.10 |
| Volume | 1,018,395 |
| Average volume (3 months) | 1,950,393 |
| Market cap | $5.3B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -211.21% |
| Earnings growth (this year) | -49.75% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +4.67% |
| P/E ratio | NM |
| Price/Sales | 1.20 |
| Price/Book | 0.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HCMHUTCHMED (China) Ltd | -0.39 | -1.24% |
| ARNAArena Pharmaceutical... | +0.15 | +0.16% |
| RAREUltragenyx Pharmaceu... | +2.11 | +3.02% |
| IONSIonis Pharmaceutical... | +0.95 | +2.96% |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | March 3, 2022 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $5.1B |
| Annual profit (last year) | -$162.6M |
| Net profit margin | -3.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
